nodes	percent_of_prediction	percent_of_DWPC	metapath
Eprosartan—Losartan—type 2 diabetes mellitus	0.21	1	CrCtD
Eprosartan—hypertension—type 2 diabetes mellitus	0.14	1	CtDrD
Eprosartan—Angiotensin 2 Receptor Antagonists—Irbesartan—type 2 diabetes mellitus	0.112	0.37	CiPCiCtD
Eprosartan—Angiotensin 2 Receptor Antagonists—Valsartan—type 2 diabetes mellitus	0.0952	0.315	CiPCiCtD
Eprosartan—Angiotensin 2 Receptor Antagonists—Losartan—type 2 diabetes mellitus	0.0952	0.315	CiPCiCtD
Eprosartan—ABCC2—type 2 diabetes mellitus	0.0707	1	CbGaD
Eprosartan—Losartan—Irbesartan—type 2 diabetes mellitus	0.0602	0.541	CrCrCtD
Eprosartan—Losartan—Valsartan—type 2 diabetes mellitus	0.0512	0.46	CrCrCtD
Eprosartan—AGTR1—Valsartan—type 2 diabetes mellitus	0.0328	0.272	CbGbCtD
Eprosartan—AGTR1—Irbesartan—type 2 diabetes mellitus	0.0293	0.243	CbGbCtD
Eprosartan—AGTR1—Losartan—type 2 diabetes mellitus	0.0189	0.156	CbGbCtD
Eprosartan—ABCC2—Glyburide—type 2 diabetes mellitus	0.00486	0.0403	CbGbCtD
Eprosartan—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.00441	0.0366	CbGbCtD
Eprosartan—CYP2C9—Glipizide—type 2 diabetes mellitus	0.00403	0.0334	CbGbCtD
Eprosartan—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.00375	0.0311	CbGbCtD
Eprosartan—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.00319	0.0264	CbGbCtD
Eprosartan—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.00319	0.0264	CbGbCtD
Eprosartan—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.00294	0.0244	CbGbCtD
Eprosartan—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.00284	0.0236	CbGbCtD
Eprosartan—CYP2C9—Valsartan—type 2 diabetes mellitus	0.0026	0.0215	CbGbCtD
Eprosartan—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.00242	0.02	CbGbCtD
Eprosartan—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.00232	0.0192	CbGbCtD
Eprosartan—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00163	0.0135	CbGbCtD
Eprosartan—CYP2C9—Losartan—type 2 diabetes mellitus	0.00149	0.0124	CbGbCtD
Eprosartan—AGTR1—artery—type 2 diabetes mellitus	0.000356	0.201	CbGeAlD
Eprosartan—AGTR1—endothelium—type 2 diabetes mellitus	0.0003	0.17	CbGeAlD
Eprosartan—AGTR1—nephron tubule—type 2 diabetes mellitus	0.000138	0.078	CbGeAlD
Eprosartan—Losartan—ACE—type 2 diabetes mellitus	0.000135	0.386	CrCbGaD
Eprosartan—AGTR1—cardiovascular system—type 2 diabetes mellitus	0.000124	0.07	CbGeAlD
Eprosartan—AGTR1—kidney—type 2 diabetes mellitus	0.000121	0.0685	CbGeAlD
Eprosartan—AGTR1—cortex of kidney—type 2 diabetes mellitus	0.000118	0.0667	CbGeAlD
Eprosartan—AGTR1—adipose tissue—type 2 diabetes mellitus	0.000109	0.0617	CbGeAlD
Eprosartan—ABCC2—nephron tubule—type 2 diabetes mellitus	9.95e-05	0.0563	CbGeAlD
Eprosartan—Losartan—CYP1A2—type 2 diabetes mellitus	9.54e-05	0.274	CrCbGaD
Eprosartan—ABCC2—kidney—type 2 diabetes mellitus	8.74e-05	0.0495	CbGeAlD
Eprosartan—ABCC2—cortex of kidney—type 2 diabetes mellitus	8.51e-05	0.0482	CbGeAlD
Eprosartan—AGTR1—liver—type 2 diabetes mellitus	7.64e-05	0.0433	CbGeAlD
Eprosartan—Losartan—CYP3A4—type 2 diabetes mellitus	6.32e-05	0.181	CrCbGaD
Eprosartan—CYP2C9—cardiovascular system—type 2 diabetes mellitus	5.95e-05	0.0337	CbGeAlD
Eprosartan—ABCC2—liver—type 2 diabetes mellitus	5.52e-05	0.0313	CbGeAlD
Eprosartan—Losartan—ALB—type 2 diabetes mellitus	5.51e-05	0.158	CrCbGaD
Eprosartan—CYP2C9—liver—type 2 diabetes mellitus	3.68e-05	0.0209	CbGeAlD
Eprosartan—Discomfort—Metformin—type 2 diabetes mellitus	1.91e-05	0.000566	CcSEcCtD
Eprosartan—Fatigue—Gliclazide—type 2 diabetes mellitus	1.91e-05	0.000566	CcSEcCtD
Eprosartan—Nausea—Glipizide—type 2 diabetes mellitus	1.91e-05	0.000564	CcSEcCtD
Eprosartan—Vomiting—Glimepiride—type 2 diabetes mellitus	1.91e-05	0.000563	CcSEcCtD
Eprosartan—Hypotension—Valsartan—type 2 diabetes mellitus	1.91e-05	0.000563	CcSEcCtD
Eprosartan—Vomiting—Sitagliptin—type 2 diabetes mellitus	1.9e-05	0.000562	CcSEcCtD
Eprosartan—Pain—Gliclazide—type 2 diabetes mellitus	1.9e-05	0.000561	CcSEcCtD
Eprosartan—Constipation—Gliclazide—type 2 diabetes mellitus	1.9e-05	0.000561	CcSEcCtD
Eprosartan—Tremor—Losartan—type 2 diabetes mellitus	1.89e-05	0.00056	CcSEcCtD
Eprosartan—Rash—Glimepiride—type 2 diabetes mellitus	1.89e-05	0.000559	CcSEcCtD
Eprosartan—Dermatitis—Glimepiride—type 2 diabetes mellitus	1.89e-05	0.000558	CcSEcCtD
Eprosartan—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	1.89e-05	0.000558	CcSEcCtD
Eprosartan—Rash—Sitagliptin—type 2 diabetes mellitus	1.88e-05	0.000557	CcSEcCtD
Eprosartan—Dermatitis—Sitagliptin—type 2 diabetes mellitus	1.88e-05	0.000556	CcSEcCtD
Eprosartan—Headache—Glimepiride—type 2 diabetes mellitus	1.88e-05	0.000555	CcSEcCtD
Eprosartan—Ill-defined disorder—Losartan—type 2 diabetes mellitus	1.87e-05	0.000554	CcSEcCtD
Eprosartan—Cough—Irbesartan—type 2 diabetes mellitus	1.87e-05	0.000554	CcSEcCtD
Eprosartan—Headache—Sitagliptin—type 2 diabetes mellitus	1.87e-05	0.000553	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	1.86e-05	0.000549	CcSEcCtD
Eprosartan—Tinnitus—Ramipril—type 2 diabetes mellitus	1.86e-05	0.000549	CcSEcCtD
Eprosartan—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	1.85e-05	0.000547	CcSEcCtD
Eprosartan—Angioedema—Losartan—type 2 diabetes mellitus	1.85e-05	0.000546	CcSEcCtD
Eprosartan—Insomnia—Valsartan—type 2 diabetes mellitus	1.84e-05	0.000545	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	1.84e-05	0.000543	CcSEcCtD
Eprosartan—Paraesthesia—Valsartan—type 2 diabetes mellitus	1.83e-05	0.000541	CcSEcCtD
Eprosartan—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	1.83e-05	0.000541	CcSEcCtD
Eprosartan—Chest pain—Irbesartan—type 2 diabetes mellitus	1.83e-05	0.00054	CcSEcCtD
Eprosartan—Myalgia—Irbesartan—type 2 diabetes mellitus	1.83e-05	0.00054	CcSEcCtD
Eprosartan—Arthralgia—Irbesartan—type 2 diabetes mellitus	1.83e-05	0.00054	CcSEcCtD
Eprosartan—Shock—Metformin—type 2 diabetes mellitus	1.83e-05	0.00054	CcSEcCtD
Eprosartan—Insomnia—Orlistat—type 2 diabetes mellitus	1.82e-05	0.000539	CcSEcCtD
Eprosartan—Malaise—Losartan—type 2 diabetes mellitus	1.82e-05	0.000539	CcSEcCtD
Eprosartan—Anxiety—Irbesartan—type 2 diabetes mellitus	1.82e-05	0.000539	CcSEcCtD
Eprosartan—Hypersensitivity—Glyburide—type 2 diabetes mellitus	1.82e-05	0.000538	CcSEcCtD
Eprosartan—Thrombocytopenia—Metformin—type 2 diabetes mellitus	1.82e-05	0.000538	CcSEcCtD
Eprosartan—Dyspnoea—Valsartan—type 2 diabetes mellitus	1.82e-05	0.000537	CcSEcCtD
Eprosartan—Vertigo—Losartan—type 2 diabetes mellitus	1.82e-05	0.000537	CcSEcCtD
Eprosartan—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	1.81e-05	0.000537	CcSEcCtD
Eprosartan—Somnolence—Valsartan—type 2 diabetes mellitus	1.81e-05	0.000536	CcSEcCtD
Eprosartan—Syncope—Losartan—type 2 diabetes mellitus	1.81e-05	0.000536	CcSEcCtD
Eprosartan—Paraesthesia—Orlistat—type 2 diabetes mellitus	1.81e-05	0.000535	CcSEcCtD
Eprosartan—Discomfort—Irbesartan—type 2 diabetes mellitus	1.81e-05	0.000534	CcSEcCtD
Eprosartan—Hyperhidrosis—Metformin—type 2 diabetes mellitus	1.79e-05	0.000531	CcSEcCtD
Eprosartan—Dyspepsia—Valsartan—type 2 diabetes mellitus	1.79e-05	0.000531	CcSEcCtD
Eprosartan—Dizziness—Bromocriptine—type 2 diabetes mellitus	1.79e-05	0.000529	CcSEcCtD
Eprosartan—Dry mouth—Irbesartan—type 2 diabetes mellitus	1.79e-05	0.000529	CcSEcCtD
Eprosartan—Palpitations—Losartan—type 2 diabetes mellitus	1.79e-05	0.000528	CcSEcCtD
Eprosartan—Nausea—Glimepiride—type 2 diabetes mellitus	1.78e-05	0.000526	CcSEcCtD
Eprosartan—Loss of consciousness—Losartan—type 2 diabetes mellitus	1.78e-05	0.000525	CcSEcCtD
Eprosartan—Nausea—Sitagliptin—type 2 diabetes mellitus	1.77e-05	0.000525	CcSEcCtD
Eprosartan—Dyspepsia—Orlistat—type 2 diabetes mellitus	1.77e-05	0.000524	CcSEcCtD
Eprosartan—Asthenia—Glyburide—type 2 diabetes mellitus	1.77e-05	0.000524	CcSEcCtD
Eprosartan—Decreased appetite—Valsartan—type 2 diabetes mellitus	1.77e-05	0.000524	CcSEcCtD
Eprosartan—Anorexia—Metformin—type 2 diabetes mellitus	1.77e-05	0.000523	CcSEcCtD
Eprosartan—Cough—Losartan—type 2 diabetes mellitus	1.76e-05	0.000521	CcSEcCtD
Eprosartan—Urticaria—Gliclazide—type 2 diabetes mellitus	1.76e-05	0.000521	CcSEcCtD
Eprosartan—Fatigue—Valsartan—type 2 diabetes mellitus	1.76e-05	0.00052	CcSEcCtD
Eprosartan—Body temperature increased—Gliclazide—type 2 diabetes mellitus	1.75e-05	0.000519	CcSEcCtD
Eprosartan—Abdominal pain—Gliclazide—type 2 diabetes mellitus	1.75e-05	0.000519	CcSEcCtD
Eprosartan—Decreased appetite—Orlistat—type 2 diabetes mellitus	1.75e-05	0.000518	CcSEcCtD
Eprosartan—Pruritus—Glyburide—type 2 diabetes mellitus	1.75e-05	0.000517	CcSEcCtD
Eprosartan—Constipation—Valsartan—type 2 diabetes mellitus	1.74e-05	0.000516	CcSEcCtD
Eprosartan—Fatigue—Orlistat—type 2 diabetes mellitus	1.74e-05	0.000514	CcSEcCtD
Eprosartan—Hypotension—Metformin—type 2 diabetes mellitus	1.73e-05	0.000513	CcSEcCtD
Eprosartan—Shock—Irbesartan—type 2 diabetes mellitus	1.72e-05	0.00051	CcSEcCtD
Eprosartan—Pain—Orlistat—type 2 diabetes mellitus	1.72e-05	0.000509	CcSEcCtD
Eprosartan—Chest pain—Losartan—type 2 diabetes mellitus	1.72e-05	0.000509	CcSEcCtD
Eprosartan—Myalgia—Losartan—type 2 diabetes mellitus	1.72e-05	0.000509	CcSEcCtD
Eprosartan—Arthralgia—Losartan—type 2 diabetes mellitus	1.72e-05	0.000509	CcSEcCtD
Eprosartan—Vomiting—Bromocriptine—type 2 diabetes mellitus	1.72e-05	0.000508	CcSEcCtD
Eprosartan—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	1.72e-05	0.000507	CcSEcCtD
Eprosartan—Anxiety—Losartan—type 2 diabetes mellitus	1.71e-05	0.000507	CcSEcCtD
Eprosartan—Tachycardia—Irbesartan—type 2 diabetes mellitus	1.71e-05	0.000506	CcSEcCtD
Eprosartan—Rash—Bromocriptine—type 2 diabetes mellitus	1.7e-05	0.000504	CcSEcCtD
Eprosartan—Dermatitis—Bromocriptine—type 2 diabetes mellitus	1.7e-05	0.000504	CcSEcCtD
Eprosartan—Tension—Ramipril—type 2 diabetes mellitus	1.7e-05	0.000503	CcSEcCtD
Eprosartan—Discomfort—Losartan—type 2 diabetes mellitus	1.7e-05	0.000503	CcSEcCtD
Eprosartan—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	1.69e-05	0.000501	CcSEcCtD
Eprosartan—Headache—Bromocriptine—type 2 diabetes mellitus	1.69e-05	0.000501	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	1.69e-05	0.0005	CcSEcCtD
Eprosartan—Diarrhoea—Glyburide—type 2 diabetes mellitus	1.69e-05	0.0005	CcSEcCtD
Eprosartan—Nervousness—Ramipril—type 2 diabetes mellitus	1.68e-05	0.000498	CcSEcCtD
Eprosartan—Dry mouth—Losartan—type 2 diabetes mellitus	1.68e-05	0.000497	CcSEcCtD
Eprosartan—Anorexia—Irbesartan—type 2 diabetes mellitus	1.67e-05	0.000494	CcSEcCtD
Eprosartan—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	1.67e-05	0.000493	CcSEcCtD
Eprosartan—Paraesthesia—Metformin—type 2 diabetes mellitus	1.67e-05	0.000493	CcSEcCtD
Eprosartan—Muscle spasms—Ramipril—type 2 diabetes mellitus	1.67e-05	0.000492	CcSEcCtD
Eprosartan—Feeling abnormal—Orlistat—type 2 diabetes mellitus	1.66e-05	0.000491	CcSEcCtD
Eprosartan—Dyspnoea—Metformin—type 2 diabetes mellitus	1.66e-05	0.000489	CcSEcCtD
Eprosartan—Somnolence—Metformin—type 2 diabetes mellitus	1.65e-05	0.000488	CcSEcCtD
Eprosartan—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	1.65e-05	0.000487	CcSEcCtD
Eprosartan—Hypotension—Irbesartan—type 2 diabetes mellitus	1.64e-05	0.000484	CcSEcCtD
Eprosartan—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	1.63e-05	0.000483	CcSEcCtD
Eprosartan—Dyspepsia—Metformin—type 2 diabetes mellitus	1.63e-05	0.000483	CcSEcCtD
Eprosartan—Tremor—Ramipril—type 2 diabetes mellitus	1.62e-05	0.00048	CcSEcCtD
Eprosartan—Shock—Losartan—type 2 diabetes mellitus	1.62e-05	0.00048	CcSEcCtD
Eprosartan—Urticaria—Valsartan—type 2 diabetes mellitus	1.62e-05	0.000479	CcSEcCtD
Eprosartan—Thrombocytopenia—Losartan—type 2 diabetes mellitus	1.61e-05	0.000477	CcSEcCtD
Eprosartan—Decreased appetite—Metformin—type 2 diabetes mellitus	1.61e-05	0.000477	CcSEcCtD
Eprosartan—Abdominal pain—Valsartan—type 2 diabetes mellitus	1.61e-05	0.000477	CcSEcCtD
Eprosartan—Tachycardia—Losartan—type 2 diabetes mellitus	1.61e-05	0.000476	CcSEcCtD
Eprosartan—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	1.61e-05	0.000475	CcSEcCtD
Eprosartan—Nausea—Bromocriptine—type 2 diabetes mellitus	1.61e-05	0.000475	CcSEcCtD
Eprosartan—Fatigue—Metformin—type 2 diabetes mellitus	1.6e-05	0.000473	CcSEcCtD
Eprosartan—Urticaria—Orlistat—type 2 diabetes mellitus	1.6e-05	0.000473	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	1.6e-05	0.000472	CcSEcCtD
Eprosartan—Hyperhidrosis—Losartan—type 2 diabetes mellitus	1.59e-05	0.000471	CcSEcCtD
Eprosartan—Abdominal pain—Orlistat—type 2 diabetes mellitus	1.59e-05	0.000471	CcSEcCtD
Eprosartan—Body temperature increased—Orlistat—type 2 diabetes mellitus	1.59e-05	0.000471	CcSEcCtD
Eprosartan—Asthenia—Gliclazide—type 2 diabetes mellitus	1.59e-05	0.000471	CcSEcCtD
Eprosartan—Constipation—Metformin—type 2 diabetes mellitus	1.59e-05	0.000469	CcSEcCtD
Eprosartan—Angioedema—Ramipril—type 2 diabetes mellitus	1.58e-05	0.000468	CcSEcCtD
Eprosartan—Paraesthesia—Irbesartan—type 2 diabetes mellitus	1.57e-05	0.000465	CcSEcCtD
Eprosartan—Anorexia—Losartan—type 2 diabetes mellitus	1.57e-05	0.000465	CcSEcCtD
Eprosartan—Vomiting—Glyburide—type 2 diabetes mellitus	1.57e-05	0.000465	CcSEcCtD
Eprosartan—Pruritus—Gliclazide—type 2 diabetes mellitus	1.57e-05	0.000464	CcSEcCtD
Eprosartan—Malaise—Ramipril—type 2 diabetes mellitus	1.56e-05	0.000462	CcSEcCtD
Eprosartan—Dyspnoea—Irbesartan—type 2 diabetes mellitus	1.56e-05	0.000462	CcSEcCtD
Eprosartan—Rash—Glyburide—type 2 diabetes mellitus	1.56e-05	0.000461	CcSEcCtD
Eprosartan—Somnolence—Irbesartan—type 2 diabetes mellitus	1.56e-05	0.000461	CcSEcCtD
Eprosartan—Dermatitis—Glyburide—type 2 diabetes mellitus	1.56e-05	0.00046	CcSEcCtD
Eprosartan—Vertigo—Ramipril—type 2 diabetes mellitus	1.56e-05	0.00046	CcSEcCtD
Eprosartan—Syncope—Ramipril—type 2 diabetes mellitus	1.55e-05	0.000459	CcSEcCtD
Eprosartan—Headache—Glyburide—type 2 diabetes mellitus	1.55e-05	0.000458	CcSEcCtD
Eprosartan—Dyspepsia—Irbesartan—type 2 diabetes mellitus	1.54e-05	0.000456	CcSEcCtD
Eprosartan—Hypotension—Losartan—type 2 diabetes mellitus	1.54e-05	0.000456	CcSEcCtD
Eprosartan—Palpitations—Ramipril—type 2 diabetes mellitus	1.53e-05	0.000453	CcSEcCtD
Eprosartan—Feeling abnormal—Metformin—type 2 diabetes mellitus	1.53e-05	0.000452	CcSEcCtD
Eprosartan—Decreased appetite—Irbesartan—type 2 diabetes mellitus	1.52e-05	0.00045	CcSEcCtD
Eprosartan—Loss of consciousness—Ramipril—type 2 diabetes mellitus	1.52e-05	0.00045	CcSEcCtD
Eprosartan—Diarrhoea—Gliclazide—type 2 diabetes mellitus	1.52e-05	0.000449	CcSEcCtD
Eprosartan—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	1.52e-05	0.000449	CcSEcCtD
Eprosartan—Cough—Ramipril—type 2 diabetes mellitus	1.51e-05	0.000447	CcSEcCtD
Eprosartan—Fatigue—Irbesartan—type 2 diabetes mellitus	1.51e-05	0.000447	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	1.5e-05	0.000444	CcSEcCtD
Eprosartan—Hypersensitivity—Valsartan—type 2 diabetes mellitus	1.5e-05	0.000444	CcSEcCtD
Eprosartan—Pain—Irbesartan—type 2 diabetes mellitus	1.5e-05	0.000443	CcSEcCtD
Eprosartan—Constipation—Irbesartan—type 2 diabetes mellitus	1.5e-05	0.000443	CcSEcCtD
Eprosartan—Insomnia—Losartan—type 2 diabetes mellitus	1.49e-05	0.000441	CcSEcCtD
Eprosartan—Hypersensitivity—Orlistat—type 2 diabetes mellitus	1.48e-05	0.000439	CcSEcCtD
Eprosartan—Paraesthesia—Losartan—type 2 diabetes mellitus	1.48e-05	0.000438	CcSEcCtD
Eprosartan—Urticaria—Metformin—type 2 diabetes mellitus	1.47e-05	0.000436	CcSEcCtD
Eprosartan—Chest pain—Ramipril—type 2 diabetes mellitus	1.47e-05	0.000436	CcSEcCtD
Eprosartan—Arthralgia—Ramipril—type 2 diabetes mellitus	1.47e-05	0.000436	CcSEcCtD
Eprosartan—Myalgia—Ramipril—type 2 diabetes mellitus	1.47e-05	0.000436	CcSEcCtD
Eprosartan—Dyspnoea—Losartan—type 2 diabetes mellitus	1.47e-05	0.000435	CcSEcCtD
Eprosartan—Anxiety—Ramipril—type 2 diabetes mellitus	1.47e-05	0.000435	CcSEcCtD
Eprosartan—Nausea—Glyburide—type 2 diabetes mellitus	1.47e-05	0.000434	CcSEcCtD
Eprosartan—Abdominal pain—Metformin—type 2 diabetes mellitus	1.47e-05	0.000434	CcSEcCtD
Eprosartan—Dizziness—Gliclazide—type 2 diabetes mellitus	1.47e-05	0.000434	CcSEcCtD
Eprosartan—Somnolence—Losartan—type 2 diabetes mellitus	1.47e-05	0.000433	CcSEcCtD
Eprosartan—Asthenia—Valsartan—type 2 diabetes mellitus	1.46e-05	0.000433	CcSEcCtD
Eprosartan—Discomfort—Ramipril—type 2 diabetes mellitus	1.46e-05	0.000431	CcSEcCtD
Eprosartan—Dyspepsia—Losartan—type 2 diabetes mellitus	1.45e-05	0.000429	CcSEcCtD
Eprosartan—Asthenia—Orlistat—type 2 diabetes mellitus	1.45e-05	0.000427	CcSEcCtD
Eprosartan—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	1.44e-05	0.000427	CcSEcCtD
Eprosartan—Pruritus—Valsartan—type 2 diabetes mellitus	1.44e-05	0.000427	CcSEcCtD
Eprosartan—Dry mouth—Ramipril—type 2 diabetes mellitus	1.44e-05	0.000427	CcSEcCtD
Eprosartan—Decreased appetite—Losartan—type 2 diabetes mellitus	1.43e-05	0.000424	CcSEcCtD
Eprosartan—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	1.43e-05	0.000424	CcSEcCtD
Eprosartan—Pruritus—Orlistat—type 2 diabetes mellitus	1.43e-05	0.000421	CcSEcCtD
Eprosartan—Fatigue—Losartan—type 2 diabetes mellitus	1.42e-05	0.00042	CcSEcCtD
Eprosartan—Vomiting—Gliclazide—type 2 diabetes mellitus	1.41e-05	0.000417	CcSEcCtD
Eprosartan—Constipation—Losartan—type 2 diabetes mellitus	1.41e-05	0.000417	CcSEcCtD
Eprosartan—Pain—Losartan—type 2 diabetes mellitus	1.41e-05	0.000417	CcSEcCtD
Eprosartan—Rash—Gliclazide—type 2 diabetes mellitus	1.4e-05	0.000414	CcSEcCtD
Eprosartan—Dermatitis—Gliclazide—type 2 diabetes mellitus	1.4e-05	0.000413	CcSEcCtD
Eprosartan—Diarrhoea—Valsartan—type 2 diabetes mellitus	1.39e-05	0.000412	CcSEcCtD
Eprosartan—Urticaria—Irbesartan—type 2 diabetes mellitus	1.39e-05	0.000412	CcSEcCtD
Eprosartan—Shock—Ramipril—type 2 diabetes mellitus	1.39e-05	0.000411	CcSEcCtD
Eprosartan—Headache—Gliclazide—type 2 diabetes mellitus	1.39e-05	0.000411	CcSEcCtD
Eprosartan—Abdominal pain—Irbesartan—type 2 diabetes mellitus	1.39e-05	0.00041	CcSEcCtD
Eprosartan—Body temperature increased—Irbesartan—type 2 diabetes mellitus	1.39e-05	0.00041	CcSEcCtD
Eprosartan—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	1.38e-05	0.000409	CcSEcCtD
Eprosartan—Tachycardia—Ramipril—type 2 diabetes mellitus	1.38e-05	0.000408	CcSEcCtD
Eprosartan—Diarrhoea—Orlistat—type 2 diabetes mellitus	1.38e-05	0.000408	CcSEcCtD
Eprosartan—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	1.37e-05	0.000404	CcSEcCtD
Eprosartan—Feeling abnormal—Losartan—type 2 diabetes mellitus	1.36e-05	0.000402	CcSEcCtD
Eprosartan—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	1.35e-05	0.000399	CcSEcCtD
Eprosartan—Dizziness—Valsartan—type 2 diabetes mellitus	1.35e-05	0.000399	CcSEcCtD
Eprosartan—Anorexia—Ramipril—type 2 diabetes mellitus	1.35e-05	0.000399	CcSEcCtD
Eprosartan—Dizziness—Orlistat—type 2 diabetes mellitus	1.33e-05	0.000394	CcSEcCtD
Eprosartan—Asthenia—Metformin—type 2 diabetes mellitus	1.33e-05	0.000394	CcSEcCtD
Eprosartan—Hypotension—Ramipril—type 2 diabetes mellitus	1.32e-05	0.000391	CcSEcCtD
Eprosartan—Nausea—Gliclazide—type 2 diabetes mellitus	1.32e-05	0.00039	CcSEcCtD
Eprosartan—Pruritus—Metformin—type 2 diabetes mellitus	1.31e-05	0.000388	CcSEcCtD
Eprosartan—Urticaria—Losartan—type 2 diabetes mellitus	1.31e-05	0.000387	CcSEcCtD
Eprosartan—Abdominal pain—Losartan—type 2 diabetes mellitus	1.3e-05	0.000385	CcSEcCtD
Eprosartan—Body temperature increased—Losartan—type 2 diabetes mellitus	1.3e-05	0.000385	CcSEcCtD
Eprosartan—Vomiting—Valsartan—type 2 diabetes mellitus	1.3e-05	0.000383	CcSEcCtD
Eprosartan—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	1.29e-05	0.000382	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	1.29e-05	0.000381	CcSEcCtD
Eprosartan—Rash—Valsartan—type 2 diabetes mellitus	1.29e-05	0.00038	CcSEcCtD
Eprosartan—Dermatitis—Valsartan—type 2 diabetes mellitus	1.28e-05	0.00038	CcSEcCtD
Eprosartan—Vomiting—Orlistat—type 2 diabetes mellitus	1.28e-05	0.000379	CcSEcCtD
Eprosartan—Insomnia—Ramipril—type 2 diabetes mellitus	1.28e-05	0.000378	CcSEcCtD
Eprosartan—Headache—Valsartan—type 2 diabetes mellitus	1.28e-05	0.000378	CcSEcCtD
Eprosartan—Diarrhoea—Metformin—type 2 diabetes mellitus	1.27e-05	0.000376	CcSEcCtD
Eprosartan—Rash—Orlistat—type 2 diabetes mellitus	1.27e-05	0.000376	CcSEcCtD
Eprosartan—Paraesthesia—Ramipril—type 2 diabetes mellitus	1.27e-05	0.000375	CcSEcCtD
Eprosartan—Dermatitis—Orlistat—type 2 diabetes mellitus	1.27e-05	0.000375	CcSEcCtD
Eprosartan—Headache—Orlistat—type 2 diabetes mellitus	1.26e-05	0.000373	CcSEcCtD
Eprosartan—Dyspnoea—Ramipril—type 2 diabetes mellitus	1.26e-05	0.000373	CcSEcCtD
Eprosartan—Asthenia—Irbesartan—type 2 diabetes mellitus	1.26e-05	0.000372	CcSEcCtD
Eprosartan—Somnolence—Ramipril—type 2 diabetes mellitus	1.26e-05	0.000372	CcSEcCtD
Eprosartan—Dyspepsia—Ramipril—type 2 diabetes mellitus	1.24e-05	0.000368	CcSEcCtD
Eprosartan—Pruritus—Irbesartan—type 2 diabetes mellitus	1.24e-05	0.000367	CcSEcCtD
Eprosartan—Decreased appetite—Ramipril—type 2 diabetes mellitus	1.23e-05	0.000363	CcSEcCtD
Eprosartan—Dizziness—Metformin—type 2 diabetes mellitus	1.23e-05	0.000363	CcSEcCtD
Eprosartan—Fatigue—Ramipril—type 2 diabetes mellitus	1.22e-05	0.00036	CcSEcCtD
Eprosartan—Hypersensitivity—Losartan—type 2 diabetes mellitus	1.21e-05	0.000359	CcSEcCtD
Eprosartan—Nausea—Valsartan—type 2 diabetes mellitus	1.21e-05	0.000358	CcSEcCtD
Eprosartan—Constipation—Ramipril—type 2 diabetes mellitus	1.21e-05	0.000358	CcSEcCtD
Eprosartan—Diarrhoea—Irbesartan—type 2 diabetes mellitus	1.2e-05	0.000354	CcSEcCtD
Eprosartan—Nausea—Orlistat—type 2 diabetes mellitus	1.2e-05	0.000354	CcSEcCtD
Eprosartan—Asthenia—Losartan—type 2 diabetes mellitus	1.18e-05	0.00035	CcSEcCtD
Eprosartan—Vomiting—Metformin—type 2 diabetes mellitus	1.18e-05	0.000349	CcSEcCtD
Eprosartan—Rash—Metformin—type 2 diabetes mellitus	1.17e-05	0.000346	CcSEcCtD
Eprosartan—Dermatitis—Metformin—type 2 diabetes mellitus	1.17e-05	0.000346	CcSEcCtD
Eprosartan—Pruritus—Losartan—type 2 diabetes mellitus	1.17e-05	0.000345	CcSEcCtD
Eprosartan—Feeling abnormal—Ramipril—type 2 diabetes mellitus	1.17e-05	0.000345	CcSEcCtD
Eprosartan—Headache—Metformin—type 2 diabetes mellitus	1.16e-05	0.000344	CcSEcCtD
Eprosartan—Dizziness—Irbesartan—type 2 diabetes mellitus	1.16e-05	0.000343	CcSEcCtD
Eprosartan—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	1.16e-05	0.000342	CcSEcCtD
Eprosartan—Diarrhoea—Losartan—type 2 diabetes mellitus	1.13e-05	0.000334	CcSEcCtD
Eprosartan—Urticaria—Ramipril—type 2 diabetes mellitus	1.12e-05	0.000332	CcSEcCtD
Eprosartan—Body temperature increased—Ramipril—type 2 diabetes mellitus	1.12e-05	0.00033	CcSEcCtD
Eprosartan—Abdominal pain—Ramipril—type 2 diabetes mellitus	1.12e-05	0.00033	CcSEcCtD
Eprosartan—Vomiting—Irbesartan—type 2 diabetes mellitus	1.11e-05	0.000329	CcSEcCtD
Eprosartan—Rash—Irbesartan—type 2 diabetes mellitus	1.1e-05	0.000327	CcSEcCtD
Eprosartan—Dermatitis—Irbesartan—type 2 diabetes mellitus	1.1e-05	0.000326	CcSEcCtD
Eprosartan—Nausea—Metformin—type 2 diabetes mellitus	1.1e-05	0.000326	CcSEcCtD
Eprosartan—Headache—Irbesartan—type 2 diabetes mellitus	1.1e-05	0.000325	CcSEcCtD
Eprosartan—Dizziness—Losartan—type 2 diabetes mellitus	1.09e-05	0.000322	CcSEcCtD
Eprosartan—Vomiting—Losartan—type 2 diabetes mellitus	1.05e-05	0.00031	CcSEcCtD
Eprosartan—Hypersensitivity—Ramipril—type 2 diabetes mellitus	1.04e-05	0.000308	CcSEcCtD
Eprosartan—Nausea—Irbesartan—type 2 diabetes mellitus	1.04e-05	0.000308	CcSEcCtD
Eprosartan—Rash—Losartan—type 2 diabetes mellitus	1.04e-05	0.000307	CcSEcCtD
Eprosartan—Dermatitis—Losartan—type 2 diabetes mellitus	1.04e-05	0.000307	CcSEcCtD
Eprosartan—Headache—Losartan—type 2 diabetes mellitus	1.03e-05	0.000305	CcSEcCtD
Eprosartan—Asthenia—Ramipril—type 2 diabetes mellitus	1.01e-05	0.0003	CcSEcCtD
Eprosartan—Pruritus—Ramipril—type 2 diabetes mellitus	1e-05	0.000296	CcSEcCtD
Eprosartan—Nausea—Losartan—type 2 diabetes mellitus	9.79e-06	0.00029	CcSEcCtD
Eprosartan—Diarrhoea—Ramipril—type 2 diabetes mellitus	9.67e-06	0.000286	CcSEcCtD
Eprosartan—Dizziness—Ramipril—type 2 diabetes mellitus	9.35e-06	0.000276	CcSEcCtD
Eprosartan—Vomiting—Ramipril—type 2 diabetes mellitus	8.99e-06	0.000266	CcSEcCtD
Eprosartan—Rash—Ramipril—type 2 diabetes mellitus	8.91e-06	0.000264	CcSEcCtD
Eprosartan—Dermatitis—Ramipril—type 2 diabetes mellitus	8.91e-06	0.000263	CcSEcCtD
Eprosartan—Headache—Ramipril—type 2 diabetes mellitus	8.86e-06	0.000262	CcSEcCtD
Eprosartan—AGTR1—GPCR downstream signaling—ADRA2A—type 2 diabetes mellitus	8.68e-06	0.000963	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—GHRL—type 2 diabetes mellitus	8.65e-06	0.000959	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—CYP2E1—type 2 diabetes mellitus	8.58e-06	0.000952	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CALCA—type 2 diabetes mellitus	8.54e-06	0.000947	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—EDNRB—type 2 diabetes mellitus	8.53e-06	0.000946	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	8.49e-06	0.000941	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—CYP1A2—type 2 diabetes mellitus	8.49e-06	0.000941	CbGpPWpGaD
Eprosartan—CYP2C9—Metapathway biotransformation—CYP2E1—type 2 diabetes mellitus	8.46e-06	0.000939	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	8.44e-06	0.000936	CbGpPWpGaD
Eprosartan—Nausea—Ramipril—type 2 diabetes mellitus	8.4e-06	0.000248	CcSEcCtD
Eprosartan—ABCC2—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	8.39e-06	0.00093	CbGpPWpGaD
Eprosartan—CYP2C9—Metapathway biotransformation—CYP1A2—type 2 diabetes mellitus	8.37e-06	0.000928	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—GIP—type 2 diabetes mellitus	8.36e-06	0.000928	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—HTR2C—type 2 diabetes mellitus	8.28e-06	0.000919	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—CYP3A4—type 2 diabetes mellitus	8.28e-06	0.000918	CbGpPWpGaD
Eprosartan—CYP2C9—Metapathway biotransformation—CYP3A4—type 2 diabetes mellitus	8.16e-06	0.000905	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—EDNRA—type 2 diabetes mellitus	8.06e-06	0.000894	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—LEPR—type 2 diabetes mellitus	7.95e-06	0.000881	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—type 2 diabetes mellitus	7.93e-06	0.000879	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—GCG—type 2 diabetes mellitus	7.91e-06	0.000877	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—ADRA2A—type 2 diabetes mellitus	7.89e-06	0.000875	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—GHRL—type 2 diabetes mellitus	7.85e-06	0.000871	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—RASGRP1—type 2 diabetes mellitus	7.78e-06	0.000863	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CALCA—type 2 diabetes mellitus	7.76e-06	0.00086	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—CCL2—type 2 diabetes mellitus	7.74e-06	0.000858	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	7.59e-06	0.000842	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	7.39e-06	0.00082	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—TLE4—type 2 diabetes mellitus	7.39e-06	0.000819	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—GCG—type 2 diabetes mellitus	7.18e-06	0.000797	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—OXCT1—type 2 diabetes mellitus	7.18e-06	0.000796	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—ADRB3—type 2 diabetes mellitus	7.11e-06	0.000789	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	7.07e-06	0.000784	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	7.05e-06	0.000782	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A1—type 2 diabetes mellitus	6.99e-06	0.000776	CbGpPWpGaD
Eprosartan—ABCC2—NRF2 pathway—TGFB1—type 2 diabetes mellitus	6.88e-06	0.000763	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CRHR1—type 2 diabetes mellitus	6.87e-06	0.000762	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	6.82e-06	0.000756	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	6.76e-06	0.00075	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—AVP—type 2 diabetes mellitus	6.73e-06	0.000746	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—STAR—type 2 diabetes mellitus	6.67e-06	0.00074	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—HSD17B3—type 2 diabetes mellitus	6.67e-06	0.00074	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—ACACA—type 2 diabetes mellitus	6.67e-06	0.00074	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—GSTM1—type 2 diabetes mellitus	6.5e-06	0.000721	CbGpPWpGaD
Eprosartan—CYP2C9—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	6.41e-06	0.000711	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	6.4e-06	0.000709	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	6.34e-06	0.000703	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	6.28e-06	0.000697	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—SPRY2—type 2 diabetes mellitus	6.28e-06	0.000697	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—GNB3—type 2 diabetes mellitus	6.19e-06	0.000687	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—RBP4—type 2 diabetes mellitus	6.12e-06	0.000679	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—GLP1R—type 2 diabetes mellitus	6.12e-06	0.000679	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—AVP—type 2 diabetes mellitus	6.11e-06	0.000677	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—MMP3—type 2 diabetes mellitus	6.11e-06	0.000677	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 2 diabetes mellitus	6.09e-06	0.000676	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	6.08e-06	0.000674	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—NCOA6—type 2 diabetes mellitus	6.05e-06	0.000671	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCKAR—type 2 diabetes mellitus	6.02e-06	0.000668	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—HSD11B1—type 2 diabetes mellitus	5.95e-06	0.00066	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	5.83e-06	0.000646	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—EDN1—type 2 diabetes mellitus	5.81e-06	0.000644	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	5.8e-06	0.000644	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	5.75e-06	0.000638	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	5.72e-06	0.000634	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—C3—type 2 diabetes mellitus	5.59e-06	0.00062	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	5.56e-06	0.000616	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	5.52e-06	0.000612	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	5.46e-06	0.000605	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—IAPP—type 2 diabetes mellitus	5.42e-06	0.000601	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—INSR—type 2 diabetes mellitus	5.39e-06	0.000598	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—AGT—type 2 diabetes mellitus	5.31e-06	0.000589	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—TRPC6—type 2 diabetes mellitus	5.29e-06	0.000587	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	5.29e-06	0.000587	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—AGTR2—type 2 diabetes mellitus	5.26e-06	0.000584	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	5.2e-06	0.000576	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CCR5—type 2 diabetes mellitus	5.19e-06	0.000576	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—C3—type 2 diabetes mellitus	5.08e-06	0.000563	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—LPA—type 2 diabetes mellitus	5.06e-06	0.000561	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B2—type 2 diabetes mellitus	5.06e-06	0.000561	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—EDNRB—type 2 diabetes mellitus	5.04e-06	0.000559	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—BHMT—type 2 diabetes mellitus	4.96e-06	0.00055	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	4.91e-06	0.000544	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—HTR2C—type 2 diabetes mellitus	4.89e-06	0.000543	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PSMD6—type 2 diabetes mellitus	4.89e-06	0.000543	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—AGT—type 2 diabetes mellitus	4.82e-06	0.000535	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—EDNRA—type 2 diabetes mellitus	4.76e-06	0.000528	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CALM1—type 2 diabetes mellitus	4.74e-06	0.000526	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CYBA—type 2 diabetes mellitus	4.74e-06	0.000526	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	4.69e-06	0.00052	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	4.66e-06	0.000517	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—GHRL—type 2 diabetes mellitus	4.64e-06	0.000515	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PLAT—type 2 diabetes mellitus	4.64e-06	0.000515	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CALCA—type 2 diabetes mellitus	4.58e-06	0.000508	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	4.46e-06	0.000494	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	4.4e-06	0.000488	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—AANAT—type 2 diabetes mellitus	4.34e-06	0.000481	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PTGDS—type 2 diabetes mellitus	4.34e-06	0.000481	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	4.32e-06	0.000479	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	4.3e-06	0.000476	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	4.24e-06	0.000471	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—GCG—type 2 diabetes mellitus	4.24e-06	0.000471	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	4.17e-06	0.000463	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	4.16e-06	0.000461	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	4.12e-06	0.000457	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GPD2—type 2 diabetes mellitus	4.11e-06	0.000456	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CDO1—type 2 diabetes mellitus	4.11e-06	0.000456	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	4.02e-06	0.000446	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	3.99e-06	0.000443	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	3.97e-06	0.00044	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—AK1—type 2 diabetes mellitus	3.92e-06	0.000435	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	3.9e-06	0.000433	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	3.9e-06	0.000432	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	3.88e-06	0.00043	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	3.69e-06	0.000409	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—GNB3—type 2 diabetes mellitus	3.66e-06	0.000406	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—SLC5A4—type 2 diabetes mellitus	3.62e-06	0.000401	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—MAT1A—type 2 diabetes mellitus	3.62e-06	0.000401	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—AVP—type 2 diabetes mellitus	3.61e-06	0.0004	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—MMP3—type 2 diabetes mellitus	3.61e-06	0.0004	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	3.6e-06	0.0004	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—IGF2—type 2 diabetes mellitus	3.59e-06	0.000398	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	3.58e-06	0.000397	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	3.54e-06	0.000393	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	3.54e-06	0.000392	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	3.51e-06	0.000389	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PPP1R3C—type 2 diabetes mellitus	3.49e-06	0.000388	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ND1—type 2 diabetes mellitus	3.49e-06	0.000388	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ENPP1—type 2 diabetes mellitus	3.49e-06	0.000388	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—HBA2—type 2 diabetes mellitus	3.49e-06	0.000388	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—G6PC—type 2 diabetes mellitus	3.49e-06	0.000388	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—APOB—type 2 diabetes mellitus	3.49e-06	0.000387	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	3.48e-06	0.000386	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	3.47e-06	0.000385	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—EDN1—type 2 diabetes mellitus	3.43e-06	0.000381	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GCGR—type 2 diabetes mellitus	3.38e-06	0.000375	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—LPL—type 2 diabetes mellitus	3.33e-06	0.000369	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	3.26e-06	0.000362	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	3.26e-06	0.000361	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—OXCT1—type 2 diabetes mellitus	3.2e-06	0.000354	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CYTB—type 2 diabetes mellitus	3.2e-06	0.000354	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	3.12e-06	0.000346	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—SRD5A1—type 2 diabetes mellitus	3.12e-06	0.000345	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCR5—type 2 diabetes mellitus	3.07e-06	0.00034	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—C3—type 2 diabetes mellitus	3e-06	0.000332	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ACACA—type 2 diabetes mellitus	2.97e-06	0.00033	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—STAR—type 2 diabetes mellitus	2.97e-06	0.00033	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—HSD17B3—type 2 diabetes mellitus	2.97e-06	0.00033	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	2.86e-06	0.000317	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—IRS2—type 2 diabetes mellitus	2.85e-06	0.000316	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ABCC8—type 2 diabetes mellitus	2.85e-06	0.000316	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CBS—type 2 diabetes mellitus	2.85e-06	0.000316	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—AGT—type 2 diabetes mellitus	2.85e-06	0.000316	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CALM1—type 2 diabetes mellitus	2.8e-06	0.000311	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—APOE—type 2 diabetes mellitus	2.79e-06	0.00031	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—LEP—type 2 diabetes mellitus	2.79e-06	0.00031	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.76e-06	0.000306	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—SLC5A2—type 2 diabetes mellitus	2.74e-06	0.000304	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—COX2—type 2 diabetes mellitus	2.74e-06	0.000304	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—NCOA6—type 2 diabetes mellitus	2.69e-06	0.000299	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	2.69e-06	0.000299	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—UCP3—type 2 diabetes mellitus	2.65e-06	0.000294	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—UCP2—type 2 diabetes mellitus	2.65e-06	0.000294	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—HSD11B1—type 2 diabetes mellitus	2.65e-06	0.000294	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.63e-06	0.000292	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	2.57e-06	0.000285	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PCK1—type 2 diabetes mellitus	2.49e-06	0.000276	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.49e-06	0.000276	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	2.45e-06	0.000272	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	2.39e-06	0.000265	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—INS—type 2 diabetes mellitus	2.38e-06	0.000264	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.35e-06	0.00026	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—HK1—type 2 diabetes mellitus	2.33e-06	0.000259	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	2.33e-06	0.000258	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.31e-06	0.000256	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.3e-06	0.000256	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.29e-06	0.000255	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—LPA—type 2 diabetes mellitus	2.25e-06	0.00025	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—KCNJ11—type 2 diabetes mellitus	2.25e-06	0.00025	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GCKR—type 2 diabetes mellitus	2.25e-06	0.00025	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—HSD3B2—type 2 diabetes mellitus	2.25e-06	0.00025	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.19e-06	0.000243	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	2.17e-06	0.00024	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ALDOB—type 2 diabetes mellitus	2.16e-06	0.000239	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	2.1e-06	0.000233	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.09e-06	0.000232	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.09e-06	0.000232	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	2.05e-06	0.000228	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	2.03e-06	0.000225	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GLP1R—type 2 diabetes mellitus	2.01e-06	0.000223	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—RELA—type 2 diabetes mellitus	1.97e-06	0.000218	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—SLC2A2—type 2 diabetes mellitus	1.87e-06	0.000208	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CPT1A—type 2 diabetes mellitus	1.84e-06	0.000204	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—MTR—type 2 diabetes mellitus	1.84e-06	0.000204	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—NAMPT—type 2 diabetes mellitus	1.8e-06	0.0002	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.79e-06	0.000199	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	1.79e-06	0.000199	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—HBA1—type 2 diabetes mellitus	1.79e-06	0.000198	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—LIPC—type 2 diabetes mellitus	1.79e-06	0.000198	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GCK—type 2 diabetes mellitus	1.79e-06	0.000198	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CYP11A1—type 2 diabetes mellitus	1.78e-06	0.000197	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.78e-06	0.000197	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.76e-06	0.000196	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—SLC9A1—type 2 diabetes mellitus	1.75e-06	0.000194	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	1.73e-06	0.000191	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.68e-06	0.000186	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.66e-06	0.000184	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.63e-06	0.00018	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	1.61e-06	0.000178	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	1.6e-06	0.000178	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	1.6e-06	0.000178	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	1.6e-06	0.000178	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	1.58e-06	0.000175	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	1.56e-06	0.000173	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.55e-06	0.000172	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.54e-06	0.000171	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	1.53e-06	0.000169	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.51e-06	0.000167	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	1.47e-06	0.000163	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	1.45e-06	0.000161	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	1.45e-06	0.000161	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	1.42e-06	0.000157	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.41e-06	0.000156	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	1.39e-06	0.000154	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	1.39e-06	0.000154	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.38e-06	0.000153	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.36e-06	0.00015	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	1.2e-06	0.000133	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.2e-06	0.000133	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	1.19e-06	0.000132	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	1.18e-06	0.000131	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	1.14e-06	0.000127	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	1.11e-06	0.000123	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	1.09e-06	0.000121	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	1.07e-06	0.000119	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	1.07e-06	0.000118	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.04e-06	0.000116	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	1.04e-06	0.000115	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	1.02e-06	0.000114	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	9.83e-07	0.000109	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	9.64e-07	0.000107	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—AKT1—type 2 diabetes mellitus	9.61e-07	0.000107	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	9.34e-07	0.000104	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	9.18e-07	0.000102	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	9.15e-07	0.000101	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	9.05e-07	0.0001	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	7.97e-07	8.84e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	7.82e-07	8.67e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	7.17e-07	7.95e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	6.86e-07	7.6e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	6.86e-07	7.6e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	6.27e-07	6.95e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	3.15e-07	3.5e-05	CbGpPWpGaD
